CSW

SEC source: 0001949798-26-000001 · wk-form4_1775597364.xml · nonDerivative · entry 1

Garde Danielle · CIK 0001949798 · SVP, Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,954

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001668461-26-000002 · wk-form4_1775597446.xml · derivative · entry 5

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,731 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001668461-26-000002 · wk-form4_1775597446.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,464

SEC source: 0001668461-26-000002 · wk-form4_1775597446.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,797

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 24 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001413614-26-000004 · wk-form4_1775597486.xml · derivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,186

Underlying: Common Stock · 9,186 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001413614-26-000004 · wk-form4_1775597486.xml · derivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,422 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001413614-26-000004 · wk-form4_1775597486.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,994

SEC source: 0001413614-26-000004 · wk-form4_1775597486.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in three equal amounts, at a rate between 0% and 200%, during three performance cycles beginning April 1, 2021 and ending on each of April 1, 2025, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. The 9,186 performance rights for the performance cycle ended April 1, 2026, along with 206 dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001413614-26-000004 · wk-form4_1775597486.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 146 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001323684-26-000003 · wk-form4_1775597381.xml · derivative · entry 4

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,037 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001323684-26-000003 · wk-form4_1775597381.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,753

SEC source: 0001323684-26-000003 · wk-form4_1775597381.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,074

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001663176-26-000001 · wk-form4_1775597306.xml · derivative · entry 4

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,037 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001663176-26-000001 · wk-form4_1775597306.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,733

SEC source: 0001663176-26-000001 · wk-form4_1775597306.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,066

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2026 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with 41 dividend equivalent units, vested at 190.7% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

SEC source: 0001413614-26-000003 · wk-form4_1774382547.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 59,526

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.

F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001519706-26-000001 · wk-form4_1773691444.xml · nonDerivative · entry 1

Ash Darron K · CIK 0001519706 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,155

SEC source: 0001413614-26-000002 · wk-form4_1771448689.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,026

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.

F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.20 to $299.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001668461-26-000001 · wk-form4_1771016702.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,450

SEC source: 0001668461-26-000001 · wk-form4_1771016702.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,950

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001323684-26-000002 · wk-form4_1771016649.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,204

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001413614-26-000001 · wk-form4_1768598258.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,526

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $324.04 to $333.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001323684-26-000001 · wk-form4_1767647032.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,204

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

SEC source: 0001413614-25-000012 · wk-form4_1765922560.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,526

F3 · kind: Represents shares that were transferred by bona fide gift to the Armes Family Foundation, a family charitable foundation in which the reporting person has no pecuniary interest. Following the gift, the reporting person disclaims beneficial ownership of the securities held by the foundation.

SEC source: 0001413614-25-000012 · wk-form4_1765922560.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,493

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

F2 · price: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $315.57 to $321.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001652531-25-000006 · wk-form4_1765922482.xml · nonDerivative · entry 1

LIVINGSTONE LINDA A. · CIK 0001652531 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,283

F1 · kind: The Reporting Person made a charitable gift of 630 shares to a nonprofit organization for which no payment or consideration was received by the Reporting Person.

SEC source: 0001663176-25-000008 · wk-form4_1765317333.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,196

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.04 to $302.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001691674-25-000005 · wk-form4_1764884210.xml · nonDerivative · entry 1

Sweezey Jay Kent · CIK 0001691674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,098

F1 · kind: The reported amount represents two separate bona fide gifts of shares to charitable organizations made on the same date. No consideration was received in either gift.

SEC source: 0002017190-25-000004 · wk-form4_1764712431.xml · nonDerivative · entry 1

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,853

SEC source: 0001668461-25-000007 · wk-form4_1764712397.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,110

SEC source: 0001668461-25-000007 · wk-form4_1764712397.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,390

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001323684-25-000008 · wk-form4_1764712344.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,349

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on November 4, 2024.

SEC source: 0002082728-25-000006 · wk-form4_1763586323.xml · nonDerivative · entry 1

WANG FANG · CIK 0002082728 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,676

SEC source: 0001413614-25-000011 · wk-form4_1763414251.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,493

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

SEC source: 0001277031-25-000005 · wk-form4_1762395307.xml · nonDerivative · entry 1

GAMBRELL MICHAEL R · CIK 0001277031 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,113

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

SEC source: 0001413614-25-000010 · wk-form4_1761941348.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,493

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.

SEC source: 0002082728-25-000005 · wk-form4_1759503813.xml · nonDerivative · entry 2

WANG FANG · CIK 0002082728 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,035

SEC source: 0002082728-25-000005 · wk-form4_1759503813.xml · nonDerivative · entry 1

WANG FANG · CIK 0002082728 · VP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,140

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0002017190-25-000003 · wk-form4_1759503795.xml · nonDerivative · entry 2

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,223

SEC source: 0002017190-25-000003 · wk-form4_1759503795.xml · nonDerivative · entry 1

UNDERWOOD JEFF · CIK 0002017190 · SVP, GM Contractor Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,693

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001949798-25-000004 · wk-form4_1759503829.xml · nonDerivative · entry 2

Garde Danielle · CIK 0001949798 · SVP, Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,782

SEC source: 0001949798-25-000004 · wk-form4_1759503829.xml · nonDerivative · entry 1

Garde Danielle · CIK 0001949798 · SVP, Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,081

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001668461-25-000005 · wk-form4_1759503801.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,520

SEC source: 0001668461-25-000005 · wk-form4_1759503801.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,012

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001413614-25-000008 · wk-form4_1759503807.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,493

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001323684-25-000007 · wk-form4_1759503824.xml · nonDerivative · entry 2

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,929

SEC source: 0001323684-25-000007 · wk-form4_1759503824.xml · nonDerivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,906

F1 · acquired: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001663176-25-000007 · wk-form4_1759503820.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,332

SEC source: 0001663176-25-000007 · wk-form4_1759503820.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,401

F1 · shares: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's 2024 Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

SEC source: 0001413614-25-000007 · wk-form4_1758055867.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,522

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on September 12, 2024.